Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The pharmacy giant is doubling down on its strengths and paying investors to wait for its transformation.

Should Investors Bail on Walgreens Stock?

Apple

Amgen

Caterpillar

Salesforce

Citi Trends

Chevron

Liquidity Services

Microsoft

UnitedHealth Group

Two new breakout stocks for Week 15 of 2021 with better than 10% short-term upside potential. This past week 2 of 4 stocks beat 10% in less than 5 days with CAMT peaking at +10.3% and HIMX +15.7%. The 2 Dow picks gained over +6.7%.

Week 15 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge

The shares of Walgreens Boots Alliance Inc (NASDAQ: WBA) have received a price target increase from $50 to $60 by Citigroup. These are the details.

WBA Stock: $60 Target (Up From $50) By Citi

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance announces the commencement of cash tender offers for up to $2,750,000,000 aggregate principal amount of certain senior notes.

Walgreens Boots Alliance Commences Tender Offer to Purchase Certain Outstanding Debt Securities

Walgreens Boots Alliance saw the pandemic elevate the importance of entrepreneurial thinking blending with corporate social responsibility. I sat down with Annie Murphy at Walgreens Boots Alliance to talk about their approach and the issues that are top of mind for the business.

How Walgreens Boots Alliance Is Embracing An Entrepreneurial Mindset

VillageMD is considering an initial public offering in what could be the latest primary care provider to become publicly-traded to boost its expansion efforts.

Walgreens-Backed VillageMD Could Be Latest Primary Care IPO

Franklin Resources

Cincinnati Financial

Colgate-Palmolive

Clorox

Con Ed

Federal Realty Investment Trust

Genuine Parts

Johnson & Johnson

Coca-Cola

Leggett & Platt

Altria

National Fuel Gas

Northwest Natural Gas

Old Republic International

Procter & Gamble

SJW Group

Telephone and Data Systems

United Bankshares

Universal Corp

V.F.

Drip Investing lists over 800 stocks that have annually increased dividends for 5 years or more. These 66 stocks boosting 40 years and more were parsed from 139 Champions posted 3/31/21. The 66 ranged from 0.76% to 6.71% in annual yield and -15.85% to 25.10% in annual price target upside estimates per brokers sampled 4/5/21.

40-Year-Plus Annual Dividend Boosters For April Are 66

DEERFIELD, Ill.--(BUSINESS WIRE)--For the seventh year in a row, Red Nose Day is back at Walgreens with the iconic Red Nose in digital form as we continue to emphasize the health and safety of customers and team members nationwide. Driven by the COVID-19 pandemic, child poverty rose as high as 21.4 percent in the United States in 20201, underscoring the urgency to support underserved children. This year, together with Comic Relief U.S., the nonprofit behind Red Nose Day, Walgreens is excited to

Walgreens and Red Nose Day Bring Back Digital Red Nose, Spreading Message of Hope, Helping to Tackle Child Poverty

American Express

Ideanomics Inc

JPMorgan Chase & Co

Ribbon Communications

Two new breakout stocks for Week 14 of 2021 with better than 10% short-term upside potential. This past week FBRX gained over 10% peaking at +14.7%. GNUS also spiked higher before bad reactions to an unclear Marvel deal spiraled into -29% decline.

Week 14 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge

Merck

The nearly 125-year-old Dow Jones is home to three superb bargains.

The 3 Best Dow Stocks to Buy for the Second Quarter (and Beyond)

Walgreens stock has made serious gains in the first quarter of 2021, but there's still plenty of room for this pharmacy-led retail stock to climb higher. The post Best Stocks For 2021: Walgreens Boots Alliance (WBA) Just Went From Seriously Undervalued to Still Undervalued appeared first on InvestorPlace.

Best Stocks For 2021: Walgreens Boots Alliance (WBA) Just Went From Seriously Undervalued to Still Undervalued

Academy Sports and Outdoors

BioNTech SE

Chewy

Micron Technology

Out of a limited number of earnings reports released in this shortened week, we'll recap here the impact of the week's five best reports.

Best Earnings Reports for Week Ending April 2, 2021

Walgreens Boots Alliance Inc. (NASDAQ:WBA) has released growing year-over-year earnings for the second quarter and boasted its administration of 8 million Covid-19 vaccines.

Walgreens Boots Alliance Posts Growing Earnings for 2nd Quarter

DEERFIELD, Ill. & CHARLESTON, S.C.--(BUSINESS WIRE)--In an effort to advance the health and well-being of communities across the U.S., today Walgreens unveiled a new myWalgreens donation feature*, which allows myWalgreens members to donate Walgreens Cash rewards directly to local nonprofits in their community via Walgreens.com or the myWalgreens app. Walgreens collaborated with in/PACT, a charitable giving platform that empowers customers to direct rewards to charities of their choice, and the

Walgreens Launches New Capability for Customers to Donate Walgreens Cash Rewards to Local Charities in Their Communities

Walgreens Boots Alliance, Inc.'s (WBA) CEO Stefano Pessina on Q2 2021 Results - Earnings Call Transcript

Retail pharmacy chain Walgreens said on Wednesday (March 31) that its latest earnings results were dragged lower by an “exceptionally weak cough, cold and flu season” that crimped its same-store sales by 3.5 percent and trimmed earnings by 10 percent. For the three months ending Feb. 28, the Illinois-based owner of 9,000 drugstores reported $32.8 […]

Walgreens' Results Hit By COVID, ‘Exceptionally Weak' Cold And Flu Season

The pharmacy giant beat earnings estimates and raised its fiscal 2021 guidance.

Why Investors Really Liked Walgreens Boots Alliance's Q2 Update

Executives at Walgreens have said the company is prepared to vaccinate millions of Americans against Covid-19. Vaccinations have been ramping up around the country, with states expanding vaccine eligibility to more adults.

Walgreens reports stronger profit as vaccine rollout ramps up

The US retail chain is launching a new bank account for its customers that will be offered online and in-store,  per Bloomberg.

Walgreens adds a bank account to its financial services offering

Walgreens (WBA) delivered earnings and revenue surprises of 27.27% and -3.15%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?

Walgreens Boots Alliance (WBA) Beats Q2 Earnings Estimates

Walgreens Boots Alliance Inc. (NASDAQ: WBA) said on Wednesday that its sales came in weaker than expected in the fiscal second quarter. The company, however, topped Wall Street estimates for per-share earnings in Q2.

Walgreens Boots Alliance reports lower than expected sales in Q2

Walgreens Boots Alliance reported $1 billion in quarterly profits, beating Wall Street's earnings expectations during a major rollout of vaccines against Covid-19 at its drugstores.

As New CEO Takes Helm, Walgreens Profits Rise Amid Vaccine Rollout

Walgreens Boots Alliance Inc. reported fiscal second-quarter net income of $1.03 billion, or $1.19 per share, up from $946.0 million, or $1.07 per share last year. Adjusted EPS of $1.40 beat the FactSet consensus for $1.10 per share.

Walgreens sales miss expectations after weak cold and flu season

Shares of Walgreens Boots Alliance (NASDAQ:WBA) moved higher by 1.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 17.11% year over year to $1.26, which beat the estimate of $1.11.

Walgreens Boots Alliance: Q2 Earnings Insights

DEERFIELD, Ill.--(BUSINESS WIRE)-- #earnings--Walgreens Boots Alliance announced that its fiscal 2021 second quarter results exceeded expectations and the company raised its fiscal 2021 guidance.

News for Walgreens Stock (WBA)